Yevich, Joseph P.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Yevich, Joseph P..The latest application filed is for "method for treatment of anxiety and depression".
- Yevich, Joseph P. - Southington CT
- Yevich, Joseph P - Southington CT
- Yevich; Joseph P. - Newburgh IN
- Yevich; Joseph P. - Evansville IN
| Patent | Date |
|---|---|
| Method for treatment of anxiety and depression App 20050137206 - Yevich, Joseph P. ; et al. | 2005-06-23 |
| S-6-hydroxy-buspirone Grant 6,821,976 - Yevich , et al. November 23, 2 | 2004-11-23 |
| R-6-hydroxy-buspirone Grant 6,686,361 - Yevich , et al. February 3, 2 | 2004-02-03 |
| Use of bioactive metabolites of gepirone for the treatment of psychological disorders App 20030220346 - Kramer, Stephen J. ; et al. | 2003-11-27 |
| Antianxiety composition App 20030069251 - Yevich, Joseph P. ; et al. | 2003-04-10 |
| R-6-hydroxy-buspirone App 20030055063 - Yevich, Joseph P. ; et al. | 2003-03-20 |
| S-6-hydroxy-buspirone App 20030022899 - Yevich, Joseph P. ; et al. | 2003-01-30 |
| Antipsychotic heterocycle compounds Grant 6,476,051 - Mattson , et al. November 5, 2 | 2002-11-05 |
| Antipsychotic heterocycle compounds App 20020072611 - Mattson, Ronald J. ; et al. | 2002-06-13 |
| Antidepressant heterocyclic compounds Grant 6,225,324 - Poss , et al. May 1, 2 | 2001-05-01 |
| Benzofuran and dihydrobenzofuran melatonergic agents Grant 5,856,529 - Catt , et al. January 5, 1 | 1999-01-05 |
| Ethylamido fluorenes and improved method of making same Grant 5,736,578 - Watson , et al. April 7, 1 | 1998-04-07 |
| Ethylamino carbazole melatonergic agents Grant 5,677,328 - Takaki , et al. October 14, 1 | 1997-10-14 |
| Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridnyl and pyrimidinylpiperazines Grant 5,618,816 - Crenshaw , et al. April 8, 1 | 1997-04-08 |
| Cerebral function enhancers: acyclic amide derivatives of pyrimidinylpiperidines Grant 5,338,738 - Matson , et al. August 16, 1 | 1994-08-16 |
| 1,3,4-oxadiazole pyschotropic compounds Grant 4,784,998 - Yevich November 15, 1 | 1988-11-15 |
| Antipsychotic cyclic imide derivatives of 2-(4-butylipiperazin-1-yl) pyridines, compositions and use Grant 4,757,073 - New , et al. July 12, 1 | 1988-07-12 |
| Antipsychotic fused-ring pyridinylpiperazine derivatives Grant 4,677,104 - New , et al. June 30, 1 | 1987-06-30 |
| Psychogeriatric 1-(2-pyrimidinyl)piperazinyl derivatives of 1-pyrrolidin-2-ones Grant 4,668,687 - Yevich , et al. May 26, 1 | 1987-05-26 |
| Antidepressant 1,2,4-triazolone compounds Grant 4,613,600 - Gammans , et al. September 23, 1 | 1986-09-23 |
| Analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives Grant 4,590,196 - Smith , et al. May 20, 1 | 1986-05-20 |
| 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives Grant 4,524,206 - New , et al. June 18, 1 | 1985-06-18 |
| Benzisothiazole and benzisoxazole piperazine derivatives Grant 4,452,799 - Temple, Jr. , et al. June 5, 1 | 1984-06-05 |
| Benzisothiazole and benzisoxazole piperazine derivatives Grant 4,411,901 - Temple, Jr. , et al. October 25, 1 | 1983-10-25 |
| 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyridines Grant 4,361,565 - Temple, Jr. , et al. November 30, 1 | 1982-11-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 